Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Supporting Patients with Cancer after Dobbs v. Jackson Women’s Health Organization
Frans L. Opdam, Beverly Moy, Edwin Choy, Andrew G. Shuman, Hans Gelderblom, Pedro C. Barata, Giuseppe Curigliano, Eric Wehrenberg-Klee, David H. Ilson, Rebecca D. Pentz, Heinz Ludwig, Suresh Senan, Jeffrey S. Ross, Timothy A. Graubert, Enrique Soto‐Pérez‐de‐Celis, Aditya Bardia, Katherine Arbour, Pierfranco Conté, Fred R. Hirsch, Herbert Chen, Jayne Gurtler, Hyman B. Muss, Eileen M. O’Reilly, Bruce A. Chabner, Benjamin O. Anderson, Antonio Tito Fojo, Evan Hall, Susan E. Bates, Michael J. Kelley, Jan B. Vermorken, Marshall R. Posner, Ahmed Idbaïh, Don S. Dizon, Carlo La Vecchia, Matti Aapro, Adrian G. Sacher, Kenneth K. Tanabe, Éduardo Bruera (2025). Supporting Patients with Cancer after Dobbs v. Jackson Women’s Health Organization. , DOI: https://doi.org/10.17615/wccx-xq34.
Article21 days agoLong-term efficacy and safety of pexidartinib in patients with tenosynovial giant cell tumor: final results of the ENLIVEN study
Andrew J. Wagner, William D. Tap, Sebastian Bauer, Jean Yves Blay, Jayesh Desai, Hans Gelderblom, Emanuela Palmerini, Christopher W. Ryan, Charles Peterfy, John H. Healey, Michiel A. J. van de Sande, Meng Qian, Dale E. Shuster, Abdul Waheed Rajper, Xin Ye, Kristen M. Tecson, Margaret Wooddell, Silvia Stacchiotti (2025). Long-term efficacy and safety of pexidartinib in patients with tenosynovial giant cell tumor: final results of the ENLIVEN study. , 30(7), DOI: https://doi.org/10.1093/oncolo/oyae345.
Article19 days agoUpdated Overall Survival and Long-Term Safety With Ripretinib Versus Sunitinib in Patients With GI Stromal Tumor: Final Overall Survival Analysis From INTRIGUE
Michael C. Heinrich, Jean Yves Blay, Hans Gelderblom, Suzanne George, Patrick Schöffski, Margaret von Mehren, John Zalcberg, Robin L. Jones, Yoon‐Koo Kang, Albiruni R. Abdul Razak, Jonathan C. Trent, Steven Attia, Axel Le Cesne, Kjetil Boye, David Goldstein, César Sánchez, Brittany L. Siontis, P. H. Cox, Erika Davis, Matthew L. Sherman, Rodrigo Ruiz‐Soto, Sebastian Bauer (2025). Updated Overall Survival and Long-Term Safety With Ripretinib Versus Sunitinib in Patients With GI Stromal Tumor: Final Overall Survival Analysis From INTRIGUE. , 43(20), DOI: https://doi.org/10.1200/jco-24-02818.
Article19 days agoLong-term clinical outcome assessments in patients with tenosynovial giant cell tumor treated with vimseltinib: 1-year results from the MOTION phase 3 trial.
Vivek A. Bhadri, Hans Gelderblom, Silvia Stacchiotti, Sebastian Bauer, Andrew J. Wagner, Michiel A. J. van de Sande, Nicholas M. Bernthal, Antonio López–Pousa, Albiruni Ryan Abdul Razak, Antoîne Italiano, Mahbubl Ahmed, Axel Le Cesne, Christopher Tait, Amanda Saunders, Nicholas Zeringo, B. Harrow, Maitreyi G. Sharma, Matthew L. Sherman, Jean Yves Blay, William D. Tap (2025). Long-term clinical outcome assessments in patients with tenosynovial giant cell tumor treated with vimseltinib: 1-year results from the MOTION phase 3 trial.. , 43(16_suppl), DOI: https://doi.org/10.1200/jco.2025.43.16_suppl.11558.
Article19 days agoProcedure for pooling clinical outcome data from DRUP-like clinical trials using the OMOP model.
Hilleke E. Hulshoff Pol, T.M. Kringelbach, Gro Live Fagereng, G. Bratseth Stav, Maria Martin Agudo, Soemeya F. Haj Mohammad, Florentine A.J. Verbeek, Hans Timmer, Loïc Verlingue, Matthew Krebs, Jean Yves Blay, Katriina Johanna Jalkanen, Kristoffer Staal Rohrberg, Henk M.W. Verheul, Ulrik Lassen, Åslaug Helland, Emile E. Voest, Eivind Hovig, Hans Gelderblom, Kjetil Taskén (2025). Procedure for pooling clinical outcome data from DRUP-like clinical trials using the OMOP model.. , 43(16_suppl), DOI: https://doi.org/10.1200/jco.2025.43.16_suppl.e23165.
Article19 days ago